Latest AI and machine learning research in alzheimer's disease for healthcare professionals.
Solid-state NMR (ssNMR) methods have continued to be developed in recent years for the efficient assignment of signals and 3D structure modeling of biomacromolecules. Consequently, we are approaching an era in which vigorous applications of these methods are more widespread in research, including functional elucidation of biomacromolecules and drug discovery. However, multidimensional ssNMR method...
Alzheimer's disease (AD) refers to a neurological disorder that causes damage to brain cells and results in decreasing cognitive abilities and memory. In brain scans, this degeneration can be seen in different ways. The disease can be classified into four stages: Non-demented (ND), moderate demented (MoD), mild demented (MiD), and very mild demented (VMD). To prepare the raw dataset for analysis, ...
BACKGROUND: In addressing elderly healthcare issues, cognitive impairment can cause significant disruptions in daily life and may potentially develop ...
Accurate and early disease detection is crucial for improving patient care, but traditional diagnostic methods often fail to identify diseases in thei...
BACKGROUND: The underdiagnosis of cognitive impairment hinders timely intervention of dementia. Health professionals working in the community play a c...
BACKGROUND AND OBJECTIVES: Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD) are progressive neurological disorders that significantly impa...
BACKGROUND: Post-stroke dementia (PSD), a common complication, diminishes rehabilitation efficacy and affects disease prognosis in stroke patients. Ma...
BACKGROUND: The field of Alzheimer's disease (AD) diagnosis is undergoing significant transformation due to the application of deep learning (DL) mode...
BACKGROUND: Alzheimer disease is a progressive neurological disorder marked by irreversible memory loss and cognitive decline. Traditional diagnostic ...
Frailty is common among older adults with chronic pain, and early identification is crucial in preventing adverse outcomes like falls, disability, and...
: In recent years, the integration of robotic systems into various aspects of daily life has become increasingly common. As these technologies continu...
BACE1Â has been regarded as an essential drug design target for treating Alzheimer's disease (AD). Multiple independent Gaussian accelerated molecular ...
INTRODUCTION: Alzheimer's disease (AD) is the most common form of dementia in the elderly. Given that AD neuropathology begins decades before symptoms...
Systemic study of pathogenic pathways and interrelationships underlying genes associated with Alzheimer's disease (AD) facilitates the identification ...
Early detection of Alzheimer's disease (AD) is crucial to maximize clinical outcomes. Most disease progression analyses include people with diagnoses ...
OBJECTIVES: In this study, we propose an interpretable deep learning radiomics (IDLR) model based on [F]FDG PET images to diagnose the clinical spectr...
Immunoglobulin light chain (AL) amyloidosis is a severe disorder caused by the accumulation of amyloid fibrils, leading to organ failure. Early diagno...
Alzheimer's disease (AD) is a chronic disease among people aged 65 and older. As the aging population continues to grow at a rapid pace, AD has emerge...
INTRODUCTION: Multiplexed PET imaging revolutionized clinical decision-making by simultaneously capturing various radiotracer data in a single scan, e...
Functional connectivity network (FCN) data from functional magnetic resonance imaging (fMRI) is increasingly used for the diagnosis of brain disorders...